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General approach to the treatment of atopic dermatitis
Mild dermatitis
Moderate dermatitis
Severe dermatitis
Acute ares
Chronic disease
Severe refractory cases, frequent ares, poor response, moderate dermatitis in young
patients
Appropriate general measures
Emollients
Weak to moderately potent topical corticosteroids (TCSs) depending on body site
Topical calcineurin inhibitors (TCIs) as second line or where corticosteroids are
contraindicated
Appropriate general measures
Emollients
Emollients
Appropriate general measures
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Potent TCSs
TCIs (tacrolimus only) on selected skin areas
Moderate-potency TCSs for maintenance
Potent TCSs for ares
TCIs (tacrolimus or pimecrolimus) as maintenance for selected skin areas
Sedating antihistamines
Systemic corticosteroids (short courses)
Moderately potent to potent TCSs in hospital
Sedating antihistamines
Thereafter, maintenance as for chronic disease
Ultraviolet (UV) light
Non-steroidal systemic drugs: azathioprine, cyclosporin, methotrexate, mycophenolate
Refer to dermatologist/paediatrician/allergist as appropriate
Potent TCSs
Phototherapy (narrow-band UVB)
Cyclosporin, methotrexate, oral corticosteroids, azathioprine, mycophenolate mofetil,
intravenous immunoglobulin, interferon-gamma
Psychotherapeutic intervention
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Guidelines for the management of atopic dermatitis
Diagnosis
Pruritus: ≥3 of the following:
Assess severity
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History of exural dermatitis (front of elbows, back of knees, front of ankles,
neck, around the eyes) or involvement of cheeks and/or extensor surfaces in
children ≥18 months of age 
Visible exural dermatitis involving the skin creases (or the cheeks and/or
extensor surfaces in children ≥18 months of age)
History of a generally dry skin in the past year
Personal history of asthma or hay fever (history of atopic disease in a
rst-degree relative in children <4 years of age)
Onset <2 years of age (used only for children ≥4 years at time of diagnosis)
Remission
Flare
Active disease
Patient education, emollients
Acute control of pruritus and
inammation
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Topical corticosteroids (TCSs)
Topical calcineurin inhibitors (TCIs)
Address reason(s) for are with
antibiotics, etc.
Adjunctive therapy
Trigger avoidance
Correct bathing
Skin care
Antibacterials
Antifungals
Antivirals
Psychological interventions
Sedating antihistamines
Maintenance therapy/chronic treatment
At the earliest sign of disease recurrence: TCIs
Long-term TCIs for selected skin areas to prevent ares, or intermittent TCSs weekly to prevent
ares
Intermittent medium-potency TCSs for ares, until subsided
Severe refractory cases, frequent ares, poor response, moderate dermatitis in young patients
Refer to dermatologist/paediatrician/allergist, as appropriate
Potent TCSs
Phototherapy (narrow-band ultraviolet B)
Cyclosporin, methotrexate, oral corticosteroids, azathioprine, mycophenolate mofetil, 
intravenous immunoglobulin, interferon-gamma
Psychotherapeutic intervention
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